Report cover image

Acquired Immunodeficiency Syndrome Industry Research Report 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 119 Pages
SKU # APRC20352415

Description

Summary

According to APO Research, The global Acquired Immunodeficiency Syndrome market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Acquired Immunodeficiency Syndrome is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Acquired Immunodeficiency Syndrome is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Acquired Immunodeficiency Syndrome is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Acquired Immunodeficiency Syndrome include Takeda, Sanofi, Novartis, Pfizer, Amgen, Merck KGaA, Daiichi Sankyo Company, Biogen and AstraZeneca Eli Lilly and Company and etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Acquired Immunodeficiency Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acquired Immunodeficiency Syndrome.
The Acquired Immunodeficiency Syndrome market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Acquired Immunodeficiency Syndrome market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Acquired Immunodeficiency Syndrome Segment by Company

Takeda
Sanofi
Novartis
Pfizer
Amgen
Merck KGaA
Daiichi Sankyo Company
Biogen
AstraZeneca Eli Lilly and Company
Actelion
Acquired Immunodeficiency Syndrome Segment by Type

Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Acquired Immunodeficiency Syndrome Segment by Application

Hospital Pharmacy
Retail Pharmacy
Others
Acquired Immunodeficiency Syndrome Segment by Application

Hospital Pharmacy
Retail Pharmacy
Others
Acquired Immunodeficiency Syndrome Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acquired Immunodeficiency Syndrome market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Acquired Immunodeficiency Syndrome and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acquired Immunodeficiency Syndrome.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Acquired Immunodeficiency Syndrome companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Table of Contents

119 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Acquired Immunodeficiency Syndrome by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
2.2.3 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
2.3 Acquired Immunodeficiency Syndrome by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Hospital Pharmacy
2.3.3 Retail Pharmacy
2.3.4 Others
2.4 Assumptions and Limitations
3 Acquired Immunodeficiency Syndrome Breakdown Data by Type
3.1 Global Acquired Immunodeficiency Syndrome Historic Market Size by Type (2020-2025)
3.2 Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Type (2026-2031)
4 Acquired Immunodeficiency Syndrome Breakdown Data by Application
4.1 Global Acquired Immunodeficiency Syndrome Historic Market Size by Application (2020-2025)
4.2 Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Acquired Immunodeficiency Syndrome Market Perspective (2020-2031)
5.2 Global Acquired Immunodeficiency Syndrome Growth Trends by Region
5.2.1 Global Acquired Immunodeficiency Syndrome Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Acquired Immunodeficiency Syndrome Historic Market Size by Region (2020-2025)
5.2.3 Acquired Immunodeficiency Syndrome Forecasted Market Size by Region (2026-2031)
5.3 Acquired Immunodeficiency Syndrome Market Dynamics
5.3.1 Acquired Immunodeficiency Syndrome Industry Trends
5.3.2 Acquired Immunodeficiency Syndrome Market Drivers
5.3.3 Acquired Immunodeficiency Syndrome Market Challenges
5.3.4 Acquired Immunodeficiency Syndrome Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Acquired Immunodeficiency Syndrome Players by Revenue
6.1.1 Global Top Acquired Immunodeficiency Syndrome Players by Revenue (2020-2025)
6.1.2 Global Acquired Immunodeficiency Syndrome Revenue Market Share by Players (2020-2025)
6.2 Global Acquired Immunodeficiency Syndrome Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Acquired Immunodeficiency Syndrome Head Office and Area Served
6.4 Global Acquired Immunodeficiency Syndrome Players, Product Type & Application
6.5 Global Acquired Immunodeficiency Syndrome Manufacturers Established Date
6.6 Global Acquired Immunodeficiency Syndrome Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Acquired Immunodeficiency Syndrome Market Size (2020-2031)
7.2 North America Acquired Immunodeficiency Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Acquired Immunodeficiency Syndrome Market Size by Country (2020-2025)
7.4 North America Acquired Immunodeficiency Syndrome Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Acquired Immunodeficiency Syndrome Market Size (2020-2031)
8.2 Europe Acquired Immunodeficiency Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Acquired Immunodeficiency Syndrome Market Size by Country (2020-2025)
8.4 Europe Acquired Immunodeficiency Syndrome Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Acquired Immunodeficiency Syndrome Market Size (2020-2031)
9.2 Asia-Pacific Acquired Immunodeficiency Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Country (2020-2025)
9.4 Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Acquired Immunodeficiency Syndrome Market Size (2020-2031)
10.2 South America Acquired Immunodeficiency Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Acquired Immunodeficiency Syndrome Market Size by Country (2020-2025)
10.4 South America Acquired Immunodeficiency Syndrome Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size (2020-2031)
11.2 Middle East & Africa Acquired Immunodeficiency Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2020-2025)
11.4 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Takeda
12.1.1 Takeda Company Information
12.1.2 Takeda Business Overview
12.1.3 Takeda Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025)
12.1.4 Takeda Acquired Immunodeficiency Syndrome Product Portfolio
12.1.5 Takeda Recent Developments
12.2 Sanofi
12.2.1 Sanofi Company Information
12.2.2 Sanofi Business Overview
12.2.3 Sanofi Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025)
12.2.4 Sanofi Acquired Immunodeficiency Syndrome Product Portfolio
12.2.5 Sanofi Recent Developments
12.3 Novartis
12.3.1 Novartis Company Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025)
12.3.4 Novartis Acquired Immunodeficiency Syndrome Product Portfolio
12.3.5 Novartis Recent Developments
12.4 Pfizer
12.4.1 Pfizer Company Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025)
12.4.4 Pfizer Acquired Immunodeficiency Syndrome Product Portfolio
12.4.5 Pfizer Recent Developments
12.5 Amgen
12.5.1 Amgen Company Information
12.5.2 Amgen Business Overview
12.5.3 Amgen Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025)
12.5.4 Amgen Acquired Immunodeficiency Syndrome Product Portfolio
12.5.5 Amgen Recent Developments
12.6 Merck KGaA
12.6.1 Merck KGaA Company Information
12.6.2 Merck KGaA Business Overview
12.6.3 Merck KGaA Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025)
12.6.4 Merck KGaA Acquired Immunodeficiency Syndrome Product Portfolio
12.6.5 Merck KGaA Recent Developments
12.7 Daiichi Sankyo Company
12.7.1 Daiichi Sankyo Company Company Information
12.7.2 Daiichi Sankyo Company Business Overview
12.7.3 Daiichi Sankyo Company Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025)
12.7.4 Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Product Portfolio
12.7.5 Daiichi Sankyo Company Recent Developments
12.8 Biogen
12.8.1 Biogen Company Information
12.8.2 Biogen Business Overview
12.8.3 Biogen Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025)
12.8.4 Biogen Acquired Immunodeficiency Syndrome Product Portfolio
12.8.5 Biogen Recent Developments
12.9 AstraZeneca Eli Lilly and Company
12.9.1 AstraZeneca Eli Lilly and Company Company Information
12.9.2 AstraZeneca Eli Lilly and Company Business Overview
12.9.3 AstraZeneca Eli Lilly and Company Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025)
12.9.4 AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Product Portfolio
12.9.5 AstraZeneca Eli Lilly and Company Recent Developments
12.10 Actelion
12.10.1 Actelion Company Information
12.10.2 Actelion Business Overview
12.10.3 Actelion Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025)
12.10.4 Actelion Acquired Immunodeficiency Syndrome Product Portfolio
12.10.5 Actelion Recent Developments
13 Report Conclusion
14 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.